Literature DB >> 8172304

Functional characterization of middle ear mucosa residues in cholesteatoma samples.

H Sudhoff1, J Bujía, A Holly, C Kim, A Fisseler-Eckhoff.   

Abstract

Cholesteatoma epithelium is characterized by a keratinocyte dysregulation with an aggressive growth that leads to the destruction of normal middle ear mucosa. The abnormal behavior of cholesteatoma epithelium seems to be induced by the presence of a heavy immune cell infiltrate releasing different cytokines and growth factors in high amounts. Middle ear mucosa rests are often observed within the cholesteatoma stroma or adjacent to the advancing front of cholesteatoma epithelium. This study investigated the presence of interleukin-1 (IL-1), transforming growth factor-alpha (TGF-alpha), epidermal growth factor (EGF), and epidermal growth factor-receptor (EGF-R) in the mucosa rests as well as the expression of an activation marker, 4F2. The findings were correlated with the features of a surrounding stroma with an enhanced immune cell infiltrate. Cholesteatoma epithelium showed a high staining intensity of IL-1, TGF-alpha, and EGF-R. In contrast to this, middle ear mucosa did not show any positive reactions for the mentioned factors. Epidermal growth factor immunoreactivity was found in neither cholesteatoma epithelium nor in middle ear mucosa residues. The authors found a high concentration of lymphocytes and macrophages in the surrounding stroma. Most of these cells expressed TGF-alpha, IL-1, and 4F2, suggesting an activated form. Results indicate that keratinocytes present in the middle ear mucosa do not appear to react to the stimuli released by the inflamed stroma, reflecting important differences in the cell biological features of the keratinocytes that form parts of both types of epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172304

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

1.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

2.  EGFR expression in acquired middle ear cholesteatoma in children and adults.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Maria de Fatima Pereira Carvalho; Jose Humberto Tavares Guerreiro Fregnani; Fernando Quintanilha Ribeiro
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

Review 3.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

4.  Mucosubstance histochemistry and pathogenesis of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-08       Impact factor: 2.503

5.  Pathogenesis of sinus cholesteatoma.

Authors:  Holger Sudhoff; Mirko Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-30       Impact factor: 3.236

6.  Analysis of histopathological aspects in acquired middle ear cholesteatoma.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Fernando de Andrade Quintanilha Ribeiro; Jose Humberto Tavares Guerreiro Fregnani
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.